NSCLC: Role of ADCs and Ongoing EVOKE-01 and EVOKE-03 Studies

Opinion
Video

Medical oncologists discuss where antibody-drug conjugates fit in the overall non–small cell lung cancer treatment landscape and review the ongoing EVOKE-01 and EVOKE-03 clinical trials.

Related Videos
Related Content